-
Announcement of the State Food and Drug Administration on Revising the Drug Insert for Alocillin Sodium for Injection (No. 108 of 2021)
Time of Update: 2021-11-14
The marketing authorization holders of the above-mentioned drugs shall be in accordance with the "Administrative Measures for Drug Registration" and other relevant regulations, in accordance with the requirements for the revision of the drug insert for azlocillin sodium for injection (see attachment), in December 2021 Report to the provincial drug supervision and administration department for the record 2 days ago .
-
Inituzumab is included in the CACA-CBCS guidelines for the first-line treatment recommendation for advanced HER2-positive breast cancer
Time of Update: 2021-11-14
As the first breast cancer anti-HER2 innovative drug independently developed by China, initumumab, a subsidiary of Sansheng Guojian, was successfully included in the recommended first-line treatment for advanced HER2-positive breast cancer .
-
Yuandong Bio-Repaglinide Metformin Tablets Obtained "Drug Registration Certificate"
Time of Update: 2021-11-14
Repaglinide and metformin tablets are compound preparations, the components of which are repaglinide and metformin hydrochloride .
It is suitable for patients who have been treated with glinide and metformin hydrochloride in combination, or treated with glinide or metformin hydrochloride monotherapy.
-
Osaikang's second biological Class 1 new drug storms the tens of billions of ophthalmology market
Time of Update: 2021-11-14
Figure 1: The latest product information declared by OsaikonSource: CDE official websiteThe announcement mentioned that ASKG712 injection can block the VEGF/VEGFR signal and effectively control the formation of new blood vessels, while also inhibiting the Ang-2 signal to improve blood vessel stability and reduce retinal inflammation, and consolidate the therapeutic effect of anti-VEGF-A .
-
Two drugs from China Resources Double-Crane's wholly-owned subsidiaries obtained "Drug Registration Certificate"
Time of Update: 2021-11-14
On November 1, China Resources Double-Crane issued an announcement stating that its wholly-owned subsidiary, China Resources SECCO, had recently received amlodipine and atorvastatin calcium tablets and sildenafil citrate tablets from the National Food and Drug Administration.
-
Eli Lilly and the U.S. government sign a $1.3 billion COVID-19 antibody supply agreement
Time of Update: 2021-11-14
In August of this year, the FDA resumed the authorization of Eli Lilly's neutralizing antibody, but only allowed to use it in states, territories and US jurisdictions where the prevalence of mutants resistant to double antibody therapy is low (less than 5%).
-
Announcement of the State Food and Drug Administration on Revising the Instructions for Creatine Phosphate Sodium for Injection (No. 105 of 2021)
Time of Update: 2021-11-14
According to the results of the adverse drug reaction assessment, in order to further ensure the safety of the public use of drugs, the State Drug Administration has decided to uniformly revise and improve the contents of the instructions for creatine phosphate sodium for injection .
-
The National Medical Insurance Administration determines the rules for renewing contracts with volume purchases
Time of Update: 2021-11-14
All provinces, autonomous regions, municipalities directly under the Central Government, and Xinjiang Production and Construction Corps Medical Insurance Bureau: To implement the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Mass Procurement of Drugs" (Guobanfa [2021] No.
-
With a series of policies vigorously boosting the development of Chinese medicine, the authentic medicinal material industry has a great opportunity
Time of Update: 2021-11-14
For example, as early as December 18, 2018, the Ministry of Agriculture and Rural Affairs of the United Nations National Drug Administration and the State Administration of Traditional Chinese Medicine jointly issued the "National Authentic Medicinal Material Production Base Construction Plan (2018-2025)", which is a guide Important documents for the development of the Chinese herbal medicine industry in the next few years are also important measures to implement the Chinese Medicine Law .
-
Zhou Song, director of Sinopharm Accord, resigns
Time of Update: 2021-11-14
On November 2, Sinopharm unanimously announced that the company’s board of directors had recently received a written resignation report from director Zhou Song . Zhou Song applied to resign as a dire
-
Six pharmaceutical companies invested more than 1 billion yuan in R&D in the first three quarters, showing strong innovation momentum
Time of Update: 2021-11-14
142 billion yuan According to the data of the 2021 third quarter report released by Hengrui Medicine, the R&D investment of Hengrui Medicine continues to increase this year.
-
The environmental protection storm in the pharmaceutical industry continues, and it has become an inevitable trend to accelerate the transition to "green"
Time of Update: 2021-11-13
Recently, the Shenyang Municipal Bureau of Ecology and Environment released the "Shenyang Municipality’s Second Round of Provincial-level Ecological Environmental Protection Inspectors' Rectification Plan", and the pollution problem of a pharmaceutical company was once again exposed .
-
Roche/Regeneron Ronapreve approved in Japan for preventive treatment of symptomatic COVID-19
Time of Update: 2021-11-13
Recently, Chugai Pharma, a Japanese pharmaceutical company controlled by Roche, recently announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan has approved the antibody cocktail therapy Ronapreve (casirivimab and imdevimab, formerly known as: REGN-COV2) as a new indication : Used to prevent symptomatic SARS-CoV-2 infection (COVID-19) .
-
Nian Shen Jinghua) Near Qiaokou in Wuhan
Time of Update: 2021-11-13
"Flying up into the sky" to describe this year's lithium The price of the ore is not exaggerated.
On October 26, Pilbara, one of Australia’s largest lithium concentrate producers, opened the third lithium concentrate auction, and the final auction price was set at US$2,350/ton.
-
The world's first targeted human interleukin-5 antibody biologics approved for marketing, Xin Kelai debuts at the 4th CIIE
Time of Update: 2021-11-13
Shanghai, November 6, 2021/PRNewswire/ - Today, at the 4th China International Import Expo, Xinkelai (generic name: mepolizumab) became the world's first target approved for marketing The identity of human interleukin-5 (IL-5) antibody biologics was officially unveiled, hoping to provide new treatment options for Chinese patients and families affected by inflammatory diseases caused by eosinophilia .
-
Based on the recognition of the great value of the field, Hillhouse still has a strong position in Biomedicine
Time of Update: 2021-11-13
In the third quarter of this year, Hillhouse Capital mainly reduced positions in the secondary market, but did not increase positions, and it disappeared from such pharmaceutical companies as Kailaiying, Tigermed, and Aier Ophthalmology .
-
"Latest Breaking News" Mentor Program Covers WeChat QQ "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
The manufacturing method of Yongan Pharmaceutical's taurine obtained a patent certificate issued by the Japanese Patent Office
Time of Update: 2021-11-13
On November 5, Yongan Pharmaceutical issued an announcement stating that the manufacturing method of taurine had recently received a patent certificate issued by the Japanese Patent Office .
-
"Latest Breaking News" A conscience mentor who seeks to bring back blood "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
"Latest News" Mentor WeChat "Mobile Sohu.com" who invested 10 yuan and earned 100
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
